Placebo-controlled trials in patients suffering from schizophrenia: Feasibility, ethical and methodological considerations

被引：0
|
作者：
Fleischhacker, WW [1 ]
Volavka, J [1 ]
Hummer, M [1 ]
Czobor, P [1 ]
机构：
[1] Univ Innsbruck, Dept Biol Psychiat, A-6020 Innsbruck, Austria
来源：
SCHIZOPHRENIA RESEARCH | 2001年 / 49卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：227 / 228
页数：2
相关论文
共 50 条
  • [1] PLACEBO CONTROLLED TRIALS IN PATIENTS SUFFERING FROM SCHIZOPHRENIA: METHODOLOGICAL ISSUES WITH AN INDIRECT EFFECT ON ETHICAL CONSIDERATIONS
    Fleischhacker, W. Wolfgang
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S15 - S15
  • [2] Placebo-controlled trials in schizophrenia: Are they ethical? Are they necessary?
    Weijer, C
    SCHIZOPHRENIA RESEARCH, 1999, 35 (03) : 211 - 218
  • [3] Methodological concerns surrounding placebo-controlled trials in schizophrenia
    Fleischhacker, W. W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 6 - 6
  • [4] Ethical considerations in placebo-controlled randomised clinical trials
    Kaufman, Kenneth R.
    BJPSYCH OPEN, 2015, 1 (01): : E3 - E4
  • [5] Placebo-controlled trials of new drugs: Ethical considerations
    Orentlicher, D
    DIABETES CARE, 2001, 24 (04) : 771 - 772
  • [6] Placebo-controlled clinical trials in multiple sclerosis: Ethical considerations
    Lublin, FD
    Reingold, SC
    ANNALS OF NEUROLOGY, 2001, 49 (05) : 677 - 681
  • [7] Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research
    McMahon, Robert P.
    Kelly, Deanna L.
    Boggs, Douglas L.
    Li, Lan
    Hu, Qiaoyan
    Davis, John M.
    Carpenter, William T., Jr.
    SCHIZOPHRENIA BULLETIN, 2008, 34 (02) : 292 - 301
  • [8] Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives
    Momper, Jeremiah D.
    Green, Dionna J.
    Park, Kyunghun
    Burckart, Gilbert J.
    Snyder, Donna L.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (02) : 282 - 303
  • [9] Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives
    Jeremiah D. Momper
    Dionna J. Green
    Kyunghun Park
    Gilbert J. Burckart
    Donna L. Snyder
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 282 - 303
  • [10] Ethical issues of placebo-controlled trials
    Ferdman, RM
    Church, JA
    JOURNAL OF PEDIATRICS, 1999, 134 (02): : 251 - 251
12345